Ovid Therapeutics | 8-K: Current report
Ovid Therapeutics | 8-K: Ovid Therapeutics Reports Business Updates and Second Quarter 2024 Financial Results
Ovid Therapeutics | 8-K: Current report
Ovid Therapeutics | 8-K: Current report
Ovid Therapeutics | 8-K: Current report
Ovid Therapeutics | 8-K: Current report
Ovid Therapeutics | 8-K: Current report
Ovid Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Ovid Therapeutics | 8-K: Ovid Therapeutics Reports Business Updates and First Quarter 2024 Financial Results
Ovid Therapeutics | DEFA14A: Others
Ovid Therapeutics | DEF 14A: Definitive information statements
Ovid Therapeutics | 8-K: Ovid Therapeutics Reports Business Updates, Fourth Quarter and Full Year 2023 Financial Results
Ovid Therapeutics | 8-K: Current report
Ovid Therapeutics | S-3: Registration statement for specified transactions by certain issuers
Ovid Therapeutics | 8-K: Ovid Therapeutics Reports Third Quarter 2023 Financial Results and Corporate Updates
Ovid Therapeutics | 8-K: Current report
Ovid Therapeutics | 8-K: Current report
Ovid Therapeutics | 8-K: Ovid Therapeutics Reports Second Quarter 2023 Financial Results and Corporate Updates
Ovid Therapeutics | 8-K: Current report
Ovid Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
No Data
No Data